MedPath

A study On The immunomodulatory activity of Corina Plus Syrup® in children of age group 1-3 years for prevention of frequent upper respiratory diseases.

Phase 3
Not yet recruiting
Conditions
Health Condition 1: J370- Chronic laryngitisHealth Condition 2: J310- Chronic rhinitisHealth Condition 3: J399- Disease of upper respiratory tract, unspecifiedHealth Condition 4: J351- Hypertrophy of tonsilsHealth Condition 5: J392- Other diseases of pharynx
Registration Number
CTRI/2024/04/065891
Lead Sponsor
Dr Sheetal D Pudale
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Children with complaints of frequent (at least 3-4 epi/3 months) upper respiratory diseases.

Exclusion Criteria

Children with LRTI, acute inflammatory pathology

Children with debilitating respiratory diseases like TB

3Children with chronic inflammatory diseases, acute respiratory infection.

Children with groin temperature more than 100F at the time of recruited.

Children with anatomical and congenital disorders.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.